Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.
about
The Role of [18F]FDG-PET/CT in Predicting Malignant Transformation of Plexiform Neurofibromas in Neurofibromatosis-1.Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
P2860
Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metabolic Tumour Burden Measur ...... with Neurofibromatosis Type-1.
@ast
Metabolic Tumour Burden Measur ...... with Neurofibromatosis Type-1.
@en
type
label
Metabolic Tumour Burden Measur ...... with Neurofibromatosis Type-1.
@ast
Metabolic Tumour Burden Measur ...... with Neurofibromatosis Type-1.
@en
prefLabel
Metabolic Tumour Burden Measur ...... with Neurofibromatosis Type-1.
@ast
Metabolic Tumour Burden Measur ...... with Neurofibromatosis Type-1.
@en
P2093
P2860
P50
P1433
P1476
Metabolic Tumour Burden Measur ...... with Neurofibromatosis Type-1.
@en
P2093
Alain Luciani
Alain Rahmouni
Emilie Sbidian
Laurence Valeyrie-Allanore
Ouidad Zehou
Pierre Brugières
Pierre Wolkenstein
Soraya Djelbani-Ahmed
P2860
P304
P356
10.1371/JOURNAL.PONE.0151809
P407
P577
2016-03-17T00:00:00Z